Efficient RNAi-induced Protein Knockdown in Somatic Cells Using Diced or Chemically Produced Small Interfering RNAs (siRNA) by Simiano Tavares, Kaio Cesar et al.
  Universidade de São Paulo
 
2012
 
Efficient RNAi-induced Protein Knockdown in
Somatic Cells Using Diced or Chemically
Produced Small Interfering RNAs (siRNA)
 
 
ACTA SCIENTIAE VETERINARIAE, PORTO ALEGRE RS, v. 40, n. 3, supl. 1, Part 2, pp. 19-23,
JAN-FEB, 2012
http://www.producao.usp.br/handle/BDPI/36237
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Sem comunidade WoS
  
 
 
 
 
 
 
 
Available in:   http://www.redalyc.org/src/inicio/ArtPdfRed.jsp?iCve=289023557003
 
 
Redalyc
Scientific Information System
Network of Scientific Journals from Latin America, the Caribbean, Spain and
Portugal
Simiano Tavares, Kaio César; de Mello e Pinho, Raquel; de Sá Carneiro, Igor; de
Aguiar, Luís Henrique; Méndez Calderón, Carlos Enrique; Tondello Martins, Leonardo;
Ambrósio, Carlos Eduardo; Maga, Elizabeth Anne; Bertolini, Marcelo; Murray, James
Donald; Relly Bertolini, Luciana
Efficient RNAi-induced Protein Knockdown in Somatic Cells Using Diced or Chemically
Produced Small Interfering RNAs (siRNA)
Acta Scientiae Veterinariae, vol. 40, núm. 3, 2012, pp. 1-11
Universidade Federal do Rio Grande do Sul
Porto Alegre, Brasil
   How to cite      Complete issue      More information about this article      Journal's homepage
Acta Scientiae Veterinariae
ISSN (Printed Version): 1678-0345
ActaSciVet@ufrgs.br
Universidade Federal do Rio Grande do Sul
Brasil
www.redalyc.org
Non-Profit Academic Project, developed under the Open Acces Initiative
Acta Scientiae Veterinariae, 2012. 40(3): 1048.
 ORIGINAL ARTICLE
    Pub. 1048
ISSN 1679-9216 (Online)
1
Received: May 2012                                                                            www.ufrgs.br/actavet                                                                        Accepted: June 2012
1Molecular and Developmental Biology Lab, School of Medicine, University of Fortaleza, Fortaleza, CE, Brazil. 2Molecular and Developmental Mor-
phophysiology Lab, School of Veterinary Medicine, University of São Paulo, São Paulo, SP, Brazil. 3Transgenics Lab, Department of Animal Science, 
University of California, Davis, CA, USA. CORRESPONDENCE: L.R. Bertolini [lrbertolini@gmail.com - Tel.: +55 (85) 9628-6893]. Molecular 
and Developmental Biology Lab, Health Sciences Center, University of Fortaleza (UNIFOR). Av. Washington Soares n. 1321, Bairro Edson Queiroz. 
CEP 60.811-905 Fortaleza, CE, Brazil.
Effi  cient RNAi-induced Protein Knockdown in Somatic Cells Using Diced                          
or Chemically Produced Small Interfering RNAs (siRNA)
Kaio César Simiano Tavares1, Raquel de Mello e Pinho1,2, Igor de Sá Carneiro1, Luís Henrique de Aguiar1, 
Carlos Enrique Méndez Calderón1, Leonardo Tondello Martins1, Carlos Eduardo Ambrósio2,
 Elizabeth Anne Maga3, Marcelo Bertolini1, James Donald Murray3 & Luciana Relly Bertolini1
ABSTRACT
Background: RNA interference (RNAi) is a post-transcriptional gene silencing process in which double-stranded RNA (dsRNA) 
directs the degradation of a specifi c corresponding target mRNA. The mediators of this process are small dsRNAs of approximately 
21 to 23 bp in length, called small interfering RNAs (siRNAs), which can be prepared in vitro and used to direct the degradation 
of specifi c mRNAs inside cells. Hence, siRNAs represent a powerful tool to study and control gene and cell function. Rapid 
progress has been made in the use of siRNA as a means to attenuate the expression of any protein for which the cDNA sequence 
is known. Individual siRNAs can be chemically synthesized, in vitro-transcribed, or expressed in cells from siRNA expression 
vectors. However, screening for the most effi cient siRNAs for post-transcriptional gene silencing in cells in culture is a laborious 
and expensive process. In this study, the effectiveness of two siRNA production strategies for the attenuation of abundant pro-
teins for DNA repair were compared in human cells: (a) the in vitro production of siRNA mixtures by the Dicer enzyme (Diced 
siRNAs); and (b) the chemical synthesis of very specifi c and unique siRNA sequences (Stealth RNaiTM). 
Materials, Methods & Results: For in vitro-produced siRNAs, two segments of the human Ku70 (167 bp in exon 5; and 249 bp 
in exon 13; NM001469) and Xrcc4 (172 bp in exon 2; and 108 bp in exon 6; NM003401) genes were chosen to generate dsRNA 
for subsequent “Dicing” to create mixtures of siRNAs. The Diced fragments of siRNA for each gene sequence were pooled and 
stored at -80oC. Alternatively, chemically synthesized Stealth siRNAs were designed and generated to match two very specifi c 
gene sequence regions for each target gene of interest (Ku70 and Xrcc4). HCT116 cells were plated at 30% confl uence in 24- or 
6-well culture plates. The next day, cells were transfected by lipofection with either Diced or Stealth siRNAs for Ku70 or Xrcc4, 
in duplicate, at various doses, with blank and sham transfections used as controls. Cells were harvested at 0, 24, 48, 72 and 96 
h post-transfection for protein determination. The knockdown of specifi c targeted gene products was quantifi ed by Western blot 
using GAPDH as control. Transfection of gene-specifi c siRNA to either Ku70 or Xrcc4 with both Diced and Stealth siRNAs 
resulted in a down regulation of the targeted proteins to approximately 10 to 20% of control levels 48 h after transfection, with 
recovery to pre-treatment levels by 96 h. 
Discussion: By transfecting cells with Diced or chemically synthesized Stealth siRNAs, Ku70 and Xrcc4, two highly expressed 
proteins in cells, were effectively attenuated, demonstrating the great potential for the use of both siRNA production strategies as 
tools to perform loss of function experiments in mammalian cells. In fact, down-regulation of Ku70 and Xrcc4 has been shown 
to reduce the activity of the non-homologous end joining DNA pathway, a very desirable approach for the use of homologous 
recombination technology for gene targeting or knockout studies. Stealth RNAiTM was developed to achieve high specifi city and 
greater stability when compared with mixtures of enzymatically-produced (Diced) siRNA fragments. In this study, both siRNA 
approaches inhibited the expression of Ku70 and Xrcc4 gene products, with no detectable toxic effects to the cells in culture. 
However, similar knockdown effects using Diced siRNAs were only attained at concentrations 10-fold higher than with Stealth 
siRNAs. The application of RNAi technology will expand and continue to provide new insights into gene regulation and as 
potential applications for new therapies, transgenic animal production and basic research.
Keywords: RNA interference, post-transcriptional gene silencing, Stealth RNAiTM, non-homologous end joining.
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INTRODUCTION
RNA interference (RNAi) is a naturally occur-
ring post-transcriptional gene silencing mechanism that 
was fi rst described in Caenorhabditis elegans [14], but 
subsequently shown as a very conserved process in a 
wide range of cell types and organisms [9,40,47]. Small 
interfering double stranded RNA fragments (siRNAs) 
are the cell mediators of the RNAi mechanism, and as 
such, siRNAs can be used in in vitro and in vivo studies 
for RNAi-induced specifi c post-transcriptional gene 
silencing [12,14,22,40,44].
Fragments of siRNA tailored for gene-
specifi c silencing can be synthesized in a number 
of ways, including the chemical synthesis, the in 
vitro or enzymatic synthesis by T7 phage RNA poly-
merase transcription from DNA templates, and the 
in vivo or vector-based synthesis within living cells 
[1,5,19,22,23,49]. Several methods based on the use 
of siRNA mixtures have been developed to increase 
targeting chances by siRNAs, including the prepara-
tion of siRNA mixtures using either RNase III [48] or 
Dicer enzymes to digest longer double-stranded RNAs 
[3,26]. The siRNA mixtures from such digestions 
have been found highly effi cient at inducing RNAi 
knockdown effects in living cells [3,11,18,39,41].
As the RNAi effectiveness of distinct siRNA 
types may differ signifi cantly among preparations, 
the aim of this study was to compare the knockdown 
effects of in vitro-produced (Diced) and chemically 
synthesized (Stealth RNAiTM) siRNAs on the rela-
tive abundance of Ku70 and Xrcc4 gene products in 
human cells. Both proteins were chosen for their 
high levels in cells and their key roles in the non-
homologous end joining (NHEJ) DNA repair pathway 
by binding and stabilizing DNA double strand breaks 
(DSBs) and mediating the DNA end joining and liga-
tion processes [8,13,20,27,28,45,46].
MATERIALS AND METHODS
In vitro production of siRNA fragments (Diced siRNA)
The system for the preparation of in vitro-
transcribed siRNA fragments, along with the strategy 
for the use of the RNAi cell machinery are illustrated 
in Figure 1. In this study, two sets of siRNA mixtures 
for each gene (Ku70 and Xrcc4) were prepared, as 
follows. Fragments of siRNA were in vitro-produced 
using primers to amplify DNA fragments from two 
different sequence regions for the Ku70 and Xrcc4 hu-
man genes (Table 1). Briefl y, genomic DNA (gDNA) 
purifi ed from HCT116 cells1 were subjected to 30 
PCR cycles, as follows: 95°C for 30 s, 56°C for 30 
s, 72°C for 45 s, and one cycle at 72°C for 7 min. 
After PCR amplifi cation, amplicons were cloned 
into the pCRTMII-TOPO® cloning vector2. DNA was 
purifi ed using the Wizard® plasmid purifi cation kit3 
and sequenced at a commercial facility4. Searches of 
the human database were carried out to ensure that 
the chosen sequences would not target other gene 
transcripts. Double-stranded RNAs (dsRNAs) were 
produced using the BLOCK-iTTM T7-TOPO® Linker2, 
according to the manufacturer’s instructions. In brief, 
the T7 promoter2 was used to generate sense and anti-
sense DNA templates from the amplicons obtained for 
each gene of interest. In vitro transcription reactions 
were done for each strand using the RNA Transcrip-
tion Kit2. Single-stranded RNAs (ssRNAs) were puri-
fi ed with the BLOCK-iTTM RNA Purifi cation Kit2, in 
vitro-annealed to generate long dsRNAs, and diced 
using the BLOCK-iTTM Dicer RNAi Kit2 to produce 
short fragments of double-stranded small interfering 
RNAs (ds-siRNAs or siRNAs). Diced siRNAs for 
both genes were quantifi ed and stored at –80oC. The 
siRNA fragments produced for the two gene sequence 
regions for each gene were pooled in equal amounts, 
by gene, prior to use in cell transfection.
Table 1. Target gene sequences, primers and GenBank accession numbers used for the in vitro production of siRNA fragments (Diced siRNA).
siRNA Target sequence Sense strand (5’-3’) Antisense strand (5’-3’) Position in 
the gene
GenBank 
accession no.
Ku70-1 167 bp, exon 5 ACGAATTCTAGAGCTTGACCAGTT TGAACAGCATGATCCTCTTATGAC 407 to 574
NM001469
Ku70-2 249 bp, exon 13 TATTCAGAAGAGGAGCTGAAGACC CCTAGCTCAGGAGAAACACATTTT 1764 to 1989
Xrcc4-1 172 bp, exon 2 CTGAATCAGAGATTTCCCAAGAAG GAGACATCTTTCAGGTTTTTCTCA 317 to 489
NM003401
Xrcc4-2 108 bp, exon 6 GATGTCACTGATATTGCACCAAGT TTCCTTTTCTTGAAGCTGATTCTC 858 to 1067
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Chemically Synthesized siRNA fragments (Stealth RNAiTM)
Two specifi c siRNA (Stealth RNAiTM 2) frag-
ments for two distinct regions of each targeting gene 
(human Ku70 and human Xrcc4; same GenBank acces-
sion numbers as in Table 1), were designed using the 
Invitrogen algorithm system5 and commercially synthe-
sized2. RNA sequences for Ku70 siRNA Stealth RNAiTM 
fragments (Ku70 Stealth siRNA) were: Ku70-1 sense 
5’-CCUCCAAUAAAGCUCUAUCGGGAAA-3’; and 
Ku70-2 sense 5’-GGAGUCGUCAGAUUAUACUG-
GAGAA-3’. RNA sequences for Xrcc4 siRNA Stealth 
RNAiTM fragments (Xrcc4 Stealth siRNA) were: Xrcc4-1 
sense 5’-CCACCUUGUUUCUGAACCCAGUAUA-3’; 
and Xrcc4-2 sense 5’-GGAAGCUUUGGAGA-
CUGAUCUUUAU-3’. A nonspecifi c Stealth siRNA2 
non homologous to any known gene (5´-UAAAU-
GUACUGCGCGUGGAGAGGAA-3´) was used as a 
control. Also, a BLOCK-iTTM fl uorescein-conjugated 
siRNA2 was used to verify transfection effi ciency. The 
two Stealth siRNAs for each gene product (Ku70 and 
Xrcc4) were tested after cell transfection, and only the 
siRNA for each gene that achieved the most effi cient 
protein knockdown with the smallest oligonucleotide 
concentration (data not shown) was selected for experi-
mental use, as below.
Gel electrophoresis for DNA and siRNA analyses
Amplicons were separated in 1.5% agarose gels 
containing ethidium bromide, in TBE buffer. Stealth 
siRNAs and Diced siRNAs for Ku70 and Xrcc4 were 
analyzed on 2% and 4% agarose gels, respectively. A 
100 bp DNA step ladder2 and a 10 bp DNA ladder2 were 
used in the experiments as molecular weight markers.
Cell cultures and cell transfections with Stealth or 
Diced siRNAs
Human (male) colon cancer HCT116 cells1 
were grown at 37°C and 5% CO2, in McCoy 5A me-
dium6 supplemented with 10% fetal calf serum (FCS)7, 
and 1% antibiotic-antimycotic solution containing 
10.000 IU sodium penicillin, 10 mg streptomycin 
sulfate and 25 µg amphotericin B7. Cells were seeded 
in six-well plates at 40-50% confl uence 24 h prior 
to siRNA transfection. Cells were treated according 
to the following siRNA treatments: (1) 0, 250, 500, 
1000 and 1500 nM Diced (pooled) siRNAs for Ku70 
or Xrcc4 gene products; (2) 40 nM (Ku70) and 20 
Figure 1. Major steps for the in vitro production of siRNA fragments (Diced siRNA) and for the strategic use 
of the RNAi pathway machinery in the cell. RNAi is a post-transcription gene silencing mechanism through 
the degradation of homologous messenger RNA (mRNA) induced by short interfering RNA (siRNA). Once in 
vitro-transcribed, percursor long double stranded RNA (dsRNA) is recognized and processed by the enzyme 
Dicer. The mixture of double-stranded processed siRNAs is transfected into cells where the RNA-induced 
silencing complex (RISC) binds and unwinds the siRNA, ultimately binding to homologous target mRNA 
for degradation, resulting in protein depletion. Modifi ed from Bertolini L.R. & Bertolini M. [2].
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nM (Xrcc4) Stealth siRNAs for Ku70 and Xrcc4 gene 
products; (3) 100 nM nonspecifi c Stealth siRNA (non-
specifi c siRNA control); (4) blank or sham transfection 
(no siRNAs; transfection control); and (5) 100 nM 
fl uorescein-conjugated siRNA (marker for transfec-
tion effi ciency). Cell transfections with siRNA frag-
ments were performed in triplicates, for each siRNA 
treatment and concentration as above, using 2 µg/mL 
Lipofectamine 20002, according to the manufacturer’s 
instructions. Lipid-RNA complexes were prepared in 
OptiMEM I2 according to the manufacturer’s instruc-
tions to be added in a drop-wise manner to the cells 
(500 µL/well) in 6-well plates, followed by a 4 to 6 h 
incubation at 38.5oC and 5% CO2. Finally, cells were 
overlaid with 2 mL culture medium containing 15% 
FCS (12% fi nal volume). At least three independent 
transfection experiments (replications) were performed 
for each siRNA treatment and concentrations.
Cells transfected with fluorescein-labeled 
siRNA, used as a control for transfection effi ciency, 
were analyzed 5 h post-lipofection by fl uorescence 
microscopy using a fl uorescein isothiocyanate fi lter 
set. The effects of Ku70 and/or Xrcc4 Diced or Stealth 
siRNA treatments and the sham and nonspecifi c siRNA 
controls on protein abundance were determined by 
Western blot at 24, 48, 72 and 96 h after transfection. 
Western blot analysis
HCT116 cells treated with different doses of 
Ku70, Xrcc4 or nonspecifi c siRNAs, as well as cells 
from sham transfections, were rinsed with PBS7 and 
lysed with 200 µL radioimmunoprecipitation (RIPA) 
buffer (50 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% 
NP-40, 0.25% sodium deoxycholate). Protein concen-
trations in each cell sample were measured using the 
Bradford Protein Assay8. Equal amounts of protein 
(5 µg) from each sample were mixed with 2x SDS 
buffer8, heated at 95°C for 5 min, and fractionated by 
10% SDS–PAGE. Gels were then transferred to Hy-
bond P nylon membranes9, blocked with TBS-T (25 
mM Tris-HCl pH 7.6, 25 mM NaCl, 0.25% Tween-20) 
containing 5% nonfat dry milk, and probed with 
primary monoclonal antibody to Ku70 (MS-329)10; 
polyclonal anti-Xrcc4 (sc-8285)11; and a monoclonal 
anti-GAPDH antibody (ab9484)12 as a loading control 
in TBS-T containing 1% nonfat dry milk for 2 h at RT. 
After washing three times in TBS-T, membranes were 
further incubated with the appropriate anti-rabbit or 
anti-mouse secondary antibodies11 conjugated to horse-
radish peroxidase (1:1000) for 1 h at RT. Membranes 
were washed three times in TBS-T, two times in TBS, 
and developed using the ECL detection kit9. Images 
were recorded and band intensities on western blots 
were quantifi ed using the CCD-based FluorChemTM 
8000 Imaging System and Alphaease FC Software13. 
Flow cytometry assay for GFP-specifi c Stealth siRNA 
activity in GFP-expressing cells
To determine the effectiveness and repeatability 
of the chemically synthesized method for RNAi-induced 
protein down regulation, including siRNA doses and 
time period for the phenotypic effects on cells, a set 
of experiments was carried out with the use of distinct 
Stealth siRNA sequences to attenuate specifi cally the 
expression of a reporter gene (green fl uorescent protein, 
GFP) in cells in culture. A GFP expression vector driven 
by the CMV promoter (pEGFP-N1)14 was linearized 
with Afl II2, resulting in a 4.8 kb DNA fragment. The 
linearized plasmid (0.5 µg per well for 24-well plate) 
was transfected into HCT116 cells (control cells) or 
co-transfected with 40 nM of six distinct chemically 
synthesized GFP-specifi c Stealth siRNA sequences 
(GFP Stealth siRNA), using the same procedures as 
for Ku70 and Xrcc4 Stealth siRNAs. Trypsinized and 
paraformaldehyde-fi xed (1%, w/v) GFP-expressing cells 
were analyzed by fl uorescence-activated cell sorting 
using a FACScan machine15 with Cell Quest software 
48 h after linear pEGFP-N1 and/or GFP Stealth siRNA 
transfections. The proportion of GFP-positive cells was 
scored in dot-plots of GFP fl uorescence versus FL3 
autofl uorescence, using mock-transfected (sham) cells 
to defi ne the negative area. A minimum of three inde-
pendent experiments conducted in duplicate for each 
GFP Stealth siRNA treatment were preformed.
Data analyses
Protein amounts obtained by densitometry 
were normalized relative to the amount of GAPDH 
in the sample. Flow cytometry data were normalized 
to control GFP cell values. Comparisons were made16 
by constructing 95% confi dence intervals on data 
regarding protein analysis by densitometry and GFP 
expression by fl ow cytometry, for P < 0.05.
RESULTS
All Diced siRNAs produced in this study 
had multiple 21-23 bp double-stranded RNA frag-
ments corresponding to each one of the targeted 
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gene sequences, for each gene of interest (Figure 2). 
Agarose gel electrophoresis (Figure 2a) confi rmed 
the correct size of resulting amplicons for each gene 
sequence of interest, which were cloned into the 
pCRTMII-TOPO® cloning vector and also sequenced 
to ensure precise templates for transcription. Two 
different DNA fragments for each gene (Table 1) 
generated pools of distinct siRNA-coding sequences; 
each siRNA-coding 21-23 mer fragments containing 
100% correct sequences.
After purifi cation (Figure 2d), the typical fi nal 
concentration of the Diced siRNA mixtures obtained 
from a single preparation were 20-45 µM (or 30-60 µg 
total siRNA in 300 µL), which was deemed suffi cient 
for many cell culture transfection experiments. The 
electrophoretic mobility of the Diced siRNA mixtures 
was positioned between the 20 and 25 bp DNA mark-
ers, which corresponded to the expected 21-23 mer 
siRNA mobility, with two overhanging nucleotides at 
each 3’ RNA end (Figure 2d). 
As observed after the fluorescent-labeled 
siRNA and GFP cell transfections, based on the detec-
tion of the fl uorescent labeling 4 h after transfection, 
and 24 h after transfection, respectively, transfection 
effi ciency was similar in all cell samples, with more 
than 90% of the cells taking up fl uorescent siRNA 
fragments after transfection.
The functional activities of different doses of 
Diced siRNAs (Figure 3), prepared using DNA frag-
ments (Table 1), and of Stealth siRNAs (Figure 4) for 
Ku70 and Xrcc4 protein depletion were examined on 
cells every 24 h for up to 96 h post-transfection. Cells 
transfected with no siRNA (sham, lipofectamine only), 
nonspecifi c siRNA, and Diced or Stealth Ku70 siRNAs 
and/or Xrcc4 siRNAs at different concentrations were 
tested by western blotting for the amount of attained 
protein knockdown, after normalization to GAPDH 
protein abundance level.
The effect of Diced Ku70 and Xrcc4 
siRNAs on Ku70 and Xrcc4 protein knockdown, 
respectively, followed a dose-dependent man-
ner, with no reciprocal attenuation effect of one 
siRNA system on the other. When compared 
with the sham and non-specific controls 48 h 
after siRNA transfection, a 250 nM Ku70 siRNA 
dose reduced endogenous Ku70 protein by 70%, 
whereas Ku70 expression was inhibited by 80 to 
90% at the 500 nM Ku70 siRNA dose (Figure 3a 
and 3c). Since the latter level of inhibition was com-
parable to the overall cell transfection efficiency 
(~90%), it seems that Ku70 expression was almost 
completely inhibited in the population of success-
fully transfected cells at 500 nM concentration and 
at 48 h post-transfection (Figure 3a). Similarly, a 
250 nM Xrcc4 siRNA dose caused a knockdown 
of approximately 80% in the Xrcc4 protein level in 
cells (48 h; Figure 3b and 3d). As expected, greater 
concentrations of Dicer Ku70 or Xrcc4 siRNAs 
did not further reduce the Ku70 or Xrcc4 protein 
abundances in transfected cells (Figure 3).
As the greatest knockdown effect was ob-
served at 48 h post-transfection, a 500 nM Dicer 
Ku70 and a 250 nM Xrcc4 siRNA doses were cho-
sen as standard concentrations for subsequent cell 
transfection experiments. When cells were trans-
fected with 500 nM Ku70 siRNA and 250 nM Xrcc4 
siRNA, Ku70 and Xrcc4 expression levels started to 
decline at 24 h, with the highest decrease observed 
at 48 h, with the return to control levels by 96 h after 
siRNA transfection (Figure 3b). The non-specific 
siRNA-treated cells had no effect on the Ku70 and 
Xrcc4 protein levels.The same successful level of 
down-regulation obtained with Dicer siRNAs was 
also observed with the use of Stealth siRNAs at 48 
h post-transfection. However, the amount required 
to achieve a 90% knockdown effect was 40 nM 
for Ku70 and 20 nM for Xrcc4, which was 10-fold 
lower than with in vitro-produced Dicer siRNA 
fragments. Also, Ku70 and Xrcc4 protein abun-
dances in Stealth siRNA-trated cells were normal 
by 96 h after Stealth siRNA transfection (Figure 
4). It is evident from western blot control data and 
from a visual inspection of treated cells that Diced 
siRNA mixtures did not show cytotoxic effects at 
the concentrations used in this study.
The fl ow cytometry assay for GFP-specifi c 
Stealth siRNA activity revealed that GFP expression 
in all groups of GFP-specifi c siRNA-treated cells was 
signifi cantly different from control cells and non-
specifi c siRNA-treated cells at 48 h post-transfection 
(Figure 5). Two siRNA sequences were effective in 
down regulating approximately 80% of the expression 
in GFP-expressing HCT116 cells, with close to 90% 
attenuation levels observed only for two GFP Stealth 
siRNA sequences (P < 0.05).
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Figure 3. Endogenous Ku70 or Xrcc4 protein abundances in HCT116 cells after transfection with Diced siRNA fragments, as quantifi ed by 
western blotting. (a) Cells transfected with different Diced Ku70 siRNA concentrations and harvested 48 h after transfection. (b) Cells were 
transfected with 500 nM Diced Ku70 siRNAs (top blot) and 250 nM Diced Xrcc4 siRNAs (bottom blot) and harvested 48 and 96 h after trans-
fection. (c) and (d) Normalized values for Ku70 and Xrcc4 protein relative abundances, relative to non-transfected control cells, at 48 and 96 h 
post-transfection with Dicer siRNA. Normalized values for Ku70 or Xrcc4 protein relative abundances were relative to non-transfected control 
cells. C: Non-transfected control  cells; NS: non-specifi c siRNA-transfected cells.
Figure 4. Stealth siRNA-mediated down-regulation of Ku70 and Xrcc4 proteins in HCT116 cells, transfected with 40 nM Stealth Ku70 siRNA 
and 20 nM Stealth Xrcc4 siRNA, and harvested at 24, 48, 72 and 96 h post-transfection. (a) Ku70 and  (b) Xrcc4 Western blots from cells col-
lected 48 h after Stealth siRNA transfection. (c) Ku70 and (d) Xrcc4 protein levels up to 96 h post-transfection, expressed as percentage values, 
after normalization against GAPDH. C: Non-transfected control cells; NS: non-specifi c siRNA-transfected cells.
Figure 2. Diced siRNA preparation and purifi cation. (a) Amplicons for Ku70 (lanes 1 and 2) and Xrcc4 (lanes 3 and 4). (b) In vitro-produced 
siRNA fragments representing 200 and 300 bp regions of the Ku70 gene, and 150 and 100 bp regions of the Xrcc4 gene. The sense and antisense 
strand for each region were annealed, showing a band biger in size than the amplicons. A high molecular weight smear is visible due to branched 
annealing products. Lanes - M: 100 bp DNA ladder, with reference values, in bp, on the left; 1: Ku70-1 sense transcript, 2: Ku70-1 antisense 
transcript, 3: Annealed Ku70 dsRNA; 4: Xrcc4-1 sense transcript; 5: Xrcc4 antisense transcript, 6: Annealed Xrcc4-1 dsRNA. (c) Enzymatic 
digestion (Diced) Ku70 and Xrcc4 ds-siRNA products prior to purifi cation. Lanes - M: 10 bp DNA ladder. (d) Purifi ed siRNA products ready 
for use. Lanes - M: 10 bp DNA ladder, with reference values, in bp, on the left.
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Figure 5. GFP-expressing HCT116 cells (%), relative to controls (GFP cells), determined by fl ow cytometry 48 h following 
co-transfection of a linear GFP expression vector and six distinct GFP-specifi c Stealth siRNA sequences. GFP cells: Non-treated 
GFP control cells; NS-siRNA: Non-specifi c siRNA-transfected GFP cells; Stealth 1 to 6: transfected GFP cells with six distinct 
GFP-specifi c Stealth siRNA sequences (1 to 6). a,b,c,d:Columns without common letters differ (P < 0.05).
DISCUSSION
RNA interference has emerged as an alternative 
and rather effi cient method for functional genomics 
studies, having the potential to become an important 
tool to enhance livestock production through the 
increase in production effi ciency, the prevention of 
diseases, for the development of therapeutic drugs, 
particularly anti-viral therapies, and also to enhance 
production of transgenic animals [2]. Proper design 
and optimal transfection conditions are critical for 
high levels of gene knockdown in RNAi experiments 
[3]. Results presented in this study demonstrated that 
the chosen target sequences and both siRNA prepa-
ration methods were effi cient for the production of 
functionally active siRNA fragments. To conduct 
a proof-of-principle experiment for effective gene 
knockdown using two distinct RNAi approaches, we 
targeted Ku70 and Xrcc4, two highly expressed genes 
in mammalian cells known to regulate DNA damage 
and DNA integration in transgenic experiments [4,29]. 
We also successfully targeted GFP expression in GFP-
expressing cells with GFP Stealth siRNAs, confi rming 
the repeatability and the robustness of the chemically 
synthesized Stealth siRNAs. In our design of the Ku70 
and Xrcc4 siRNA fragments, we chose only gene frag-
ments that contained no homology with other published 
human gene sequences, thereby expecting to minimize 
non-specifi c effects on cells. Hence, any potentially 
cross-reactive sequences (e.g., sequences that contain 
homology to closely related known targets or, per-
haps, those having minimal homology to a particular 
‘background’ genome) could be excluded from a set of 
siRNAs for optimal gene-specifi c targeting [16,32,36].
The discovery that RNAi is effective and 
can be used to transiently silence gene expression in 
mammalian cells has opened new avenues to study 
proteins in mammalian cells for genes for which 
knockout models are non-viable [6,10,43] such as is the 
case for DNA repair proteins. The use of RNAi allows 
the further investigation of DNA repair proteins in 
cancer research and also exogenous DNA integration. 
The present study demonstrated a successful transient 
depletion of Ku70 and Xrcc4 proteins, obtained by 
the transfection of siRNA fragments into HCT116 
cells. DNA repair proteins play a major role in the 
response to DNA damaging agents in mammalian cells 
[17,25] making them attractive targets considering 
the importance of DNA repair enzymes for DNA 
damage control. Our results showed that a pool of 
enzymatically produced Ku70 or Xrcc4 Diced siRNAs 
could be as effectively used to obtain a transient 
depletion of these essential proteins as Stealth siRNA, 
without any detectable detrimental or side effects on the 
cells, with the expectation that such a depletion by both 
approaches would lead to loss-of-function phenotypes.
The testing of various concentrations on 
siRNAs allowed the determination of optimum siRNA 
doses (400 nM for Ku70 and 200 nM for Xrcc4 for 
Diced siRNAs; 40 nM for Ku70 and 20 nM for Xrcc4 
for Stealth siRNAs) that yielded the maximum protein 
knockdown effects. Furthermore, the time course 
analysis showed that maximum depletion of the 
targeted protein was attained by 48 h post-transfection, 
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with protein levels returning to near normal values by 
96 h post-transfection. These fi ndings are consistent 
with previous data reporting the half-lives of these 
proteins to be in the range of 16 to 24 h [15,33]. 
The Diced siRNA mixtures significantly 
reduced Ku70 and Xrcc4 protein levels, but Western 
blot analyses showed that cellular Ku70 or Xrcc4 
expression could not be completely depleted. In 
fact, fragments of siRNA act on cells by specifically 
inducing degradation of the mRNA for the targeted 
gene, being unlikely to cause a complete transcript 
and protein depletion, with the attaining of a knock-
down or attenuating effect [12]. Transfection with 
250 nM Ku70 siRNAs down regulated around 70% 
of the Ku70 protein levels seen in the respective 
mock-transfected cells. However, transfection with 
increased concentrations of Ku70 siRNA (500 nM) 
reduced the protein levels to 10% of the amount 
seen in the mock-transfected cells. Notably, in-
creasing the concentration of siRNA even further 
did not cause a complete depletion of the protein, 
agreeing with observations by Elbashir et al. 
[12]. Each efficient siRNA has an optimum dose-
response curve relative to a maximal knockdown 
effect, which was, in this study, in the range of 500 
nM for Ku70 and 250 nM for Xrcc4. Altogether, 
the transient depletion of essential cell proteins 
over a time period of several days, without observ-
able negative effects on cell survival, suggests the 
possibility of carrying out a series of sequential 
transfections to elucidate the function of genes or 
manipulate cellular machinery for therapeutic or 
other end uses [7,31,42,50].
Like other classes of antisense agents for se-
quence-specifi c mRNA knockdowns, such as antisense 
oligonucleotides or ribozymes, effective application of 
RNAi in mammalian cells requires effi cient delivery, 
identifi cation of sensitive sites in the target RNA se-
quence, and minimization of off-target effect [30,35]. 
Two types of off-target effects have been described in the 
literature: (i) a non-specifi c effect, which is independent 
of sequence homology with a particular siRNA, and (ii) 
a specifi c effect, when non-targeted genes with partial 
complementarity to a particular siRNA directed against 
the target gene are down-regulated [21,24,34,37]. In the 
present study, we did not investigate whether our siRNA 
mixtures would cause potential off-target effects.
In summary, the present study demonstrated 
the successful transient depletion of the human 
Ku70 and Xrcc4 proteins using two distinct RNAi 
approaches. The Diced or enzymatically produced 
siRNA was the most cost effective and quickest 
method, being mediated by the T7 phage RNA 
polymerase in vitro transcription from short DNA 
fragments [38], whereas the chemically synthe-
sized stealth siRNA represented the gold standard 
for RNAi. Chemically synthesized siRNAs can be 
produced with a wide range of chemical modifi ca-
tions, making them more stable, more specifi c and 
consistent, as observed in this study. The down side, 
however, of its use include the higher manufacturing 
costs and period of time required for the synthesis 
of Stealth siRNA fragments.
CONCLUSIONS
Results from this study demonstrated the ef-
fectiveness of enzymatically produced (Diced) siRNAs 
in inhibiting abundant target proteins in cultured cells 
in a manner similar to that induced by chemically 
synthesized (Stealth) siRNAs. The in vitro production 
of siRNA mixtures is more cost effective when com-
pared with the chemical synthesis in the production 
of Stealth siRNAs. As mixtures may contain a wide 
range of distinct Diced siRNA sequences, effective 
doses to attain high protein knockdown levels (90%) 
were 10-fold higher than with the use of target-specifi c 
Stealth siRNA fragments. Also, the in vitro method 
provided siRNA fragments in larger scale, suitable for 
pharmaceutical applications or for the production of 
RNA libraries, which would be complex to be attained 
with chemically synthesized Stealth siRNA fragments.
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